During flu season, when fever, aches, and chills hit, it is easy to forget one’s manners. A recent survey of more than 1,000 Americans found that nearly two-thirds (64%) of those who had influenza in the past three years admit to being “That Guy,” who despite experiencing flu symptoms, continues to go about his/her daily activities.
As part of its “Are You That Guy?” influenza education campaign, the National Foundation for Infectious Diseases (NFID) is partnering with the Emily Post Institute to remind Americans to do the responsible thing during flu season and practice behavior that will help limit the spread of influenza, a highly contagious virus. The campaign also reminds Americans to see a doctor quickly if flu strikes. The campaign offers flu etiquette tips for managing common situations where the flu virus might be shared from one person to another, such as shaking hands during a business meeting, over a family dinner, or when faced with a fellow airplane traveler who is showing signs of flu.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53536-nfid-emily-post-institute-educate-about-spreading-manners-not-influenza
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program called Cdiffense to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection (CDI). Clostridium difficile (C. diff) is a potentially life-threatening, spore-forming bacterium that causes intestinal disease. The risk of C. diff increases with age, antibiotic treatment and time spent in hospitals or nursing homes, where multiple cases can lead to outbreaks. The investigational vaccine is designed to help protect at-risk individuals from C. diff, which is emerging as a leading cause of life-threatening, healthcare-associated infections (HAIs) worldwide.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62652-sanofi-pasteur-initiates-phase-iii-study-of-investigational-vaccine
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of Fluzone® (Influenza Vaccine) for the 2016-2017 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA) for shipment. This represents the first of more than 65 million total doses of seasonal influenza vaccine manufactured by Sanofi Pasteur that will be delivered to U.S. health care providers and pharmacies beginning in July and continuing throughout the remainder of the year. Sanofi Pasteur plans to increase its supply to respond to the shifting pediatric public health needs.
Seasonal influenza activity typically occurs between October and May and peaks between December and February. However, influenza activity peaked noticeably late last season occurring in early March 2016.1 Influenza seasons are always unpredictable as new influenza strains emerge and strain activity fluctuates throughout the year, making timely vaccination even more important to help protect against the virus, especially for seniors, young children and infants six months of age and older.
To view the multimedia release go to:
http://www.multivu.com/players/English/7842051-sanofi-pasteur-influenza-vaccine/
CVS/pharmacy and MinuteClinic announced their “You vs. Flu” campaign today. Flu vaccinations are now available at all CVS/pharmacy and MinuteClinic locations nationwide to help consumers win against the flu. CVS/pharmacy has more than 7,200 locations and MinuteClinic has nearly 600 locations inside select CVS/pharmacy stores.
Flu shots are being provided by CVS pharmacists and MinuteClinic nurse practitioners and physician assistants every day, including evenings and weekends, with no appointment necessary. The Centers for Disease Control and Prevention (CDC) recommends that everyone ages six months and older get a flu shot as soon as vaccine is available, including those who were vaccinated last flu season.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51328-cvs-minuteclinic-flu-shot
More than 300 global leaders, health and development experts, vaccinators, celebrities, philanthropists, and business leaders will gather tomorrow in Abu Dhabi in the first Global Vaccine Summit to endorse the critical role that vaccines and immunization play in giving children a healthy start to life. Despite tremendous progress, one child still dies every 20 seconds from preventable diseases like pneumonia, rotavirus, measles, and meningitis.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61396-bill-and-melinda-gates-foundation-first-global-vaccine-summit
In recent years there has been a shift in the understanding of cancer. Immunotherapy with vaccines has been emerging as the most promising direction towards a decisive improvement of treatment outcomes.
The Dendritic Cell Vaccine has received FDA approval for prostate cancer and trials are now under way for a variety of other cancers. These vaccines are usually administered on their own.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64654-issels-integrative-immunotherapy-for-standard-therapy-resistant-cancers
The United Nations Foundation’s Shot@Life campaign marks World Pneumonia Day, November 12, by asking Americans to raise awareness, funds and advocate to members of Congress to support global immunization programs. Pneumonia kills nearly a million children under the age of five each year and almost half of those deaths are vaccine-preventable.
“Around the world one in five children lack access to the vaccines they need,” said Devi Thomas, Director, UN Foundation’s Shot@Life campaign. “By raising awareness, funding and asking members of Congress to support global immunization programs we can ensure that every child, no matter where they live, is given a shot at a healthy life.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7616651-shotatlife-united-nations-vaccines/
Kiwanis International and UNICEF have joined forces to save the lives of babies and their mothers by eliminating maternal/neonatal tetanus (MNT), a disease that kills an estimated 60,000 newborns and 30,000 mothers each year. UNICEF Ambassador and actor Tea Leoni delivered the announcement at the 95th Annual Kiwanis International Convention.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/unicef/44644/
During flu season, when fever, aches, and chills hit, it is easy to forget one’s manners. A recent survey of more than 1,000 Americans found that nearly two-thirds (64%) of those who had influenza in the past three years admit to being “That Guy,” who despite experiencing flu symptoms, continues to go about his/her daily activities.
As part of its “Are You That Guy?” influenza education campaign, the National Foundation for Infectious Diseases (NFID) is partnering with the Emily Post Institute to remind Americans to do the responsible thing during flu season and practice behavior that will help limit the spread of influenza, a highly contagious virus. The campaign also reminds Americans to see a doctor quickly if flu strikes. The campaign offers flu etiquette tips for managing common situations where the flu virus might be shared from one person to another, such as shaking hands during a business meeting, over a family dinner, or when faced with a fellow airplane traveler who is showing signs of flu.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53536-nfid-emily-post-institute-educate-about-spreading-manners-not-influenza
Building upon its efforts to provide greater access to vaccines and other health care services for populations in need, Walgreens (NYSE: WAG) (Nasdaq: WAG) is partnering with the United Nations Foundation this flu season, to help provide up to 3 million life-saving vaccines to children in developing countries through a donation to the Foundation’s Shot@Life campaign.
To view Multimedia News Release, go to http://www.multivu.com/players/English/62923-walgreens-flu-season2013
Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64826-issels-recurrent-lung-cancer-responds-to-integrative-immunotherapy
AstraZeneca announced today that it has collaborated with actor and father James Van Der Beek on a campaign to dispel common myths about the flu and underscore the importance of annual influenza vaccination for eligible individuals and families. As part of the campaign, Van Der Beek stars in an informative and comedic video, called “Just the Flu Facts,” in which he uses his signature sense of humor to debunk common misconceptions about seasonal influenza that are often barriers to vaccination.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7312451-medimmune-specialty-care-james-van-der-beek-flumist-quadrivalent-encourage-flu-shot/
